172 related articles for article (PubMed ID: 21955999)
1. Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells.
Agrawal V; Woo JH; Mauldin JP; Jo C; Stone EM; Georgiou G; Frankel AE
Anticancer Drugs; 2012 Jan; 23(1):51-64. PubMed ID: 21955999
[TBL] [Abstract][Full Text] [Related]
2. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
Khoury O; Ghazale N; Stone E; El-Sibai M; Frankel AE; Abi-Habib RJ
J Neurooncol; 2015 Mar; 122(1):75-85. PubMed ID: 25567351
[TBL] [Abstract][Full Text] [Related]
3. Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells.
Tanios R; Bekdash A; Kassab E; Stone E; Georgiou G; Frankel AE; Abi-Habib RJ
Leuk Res; 2013 Nov; 37(11):1565-71. PubMed ID: 24018014
[TBL] [Abstract][Full Text] [Related]
4. [HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells.
Khalil N; Abi-Habib RJ
Invest New Drugs; 2020 Oct; 38(5):1236-1246. PubMed ID: 31823161
[TBL] [Abstract][Full Text] [Related]
5. Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.
Al-Koussa H; Al-Haddad M; Abi-Habib R; El-Sibai M
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795337
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.
Lam TL; Wong GK; Chong HC; Cheng PN; Choi SC; Chow TL; Kwok SY; Poon RT; Wheatley DN; Lo WH; Leung YC
Cancer Lett; 2009 May; 277(1):91-100. PubMed ID: 19138817
[TBL] [Abstract][Full Text] [Related]
7. Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells.
Swayden M; Bekdash A; Fakhoury I; El-Atat O; Borjac-Natour J; El-Sibai M; Abi-Habib RJ
Hum Cell; 2021 Jan; 34(1):152-164. PubMed ID: 32979152
[TBL] [Abstract][Full Text] [Related]
8. Human Recombinant Arginase I [HuArgI(Co)-PEG5000]-Induced Arginine Depletion Inhibits Pancreatic Cancer Cell Migration and Invasion Through Autophagy.
El-Mais N; Fakhoury I; Al Haddad M; Nohra S; Abi-Habib R; El-Sibai M
Pancreas; 2021 Sep; 50(8):1187-1194. PubMed ID: 34714283
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent.
Nasreddine G; El-Sibai M; Abi-Habib RJ
Invest New Drugs; 2020 Feb; 38(1):10-19. PubMed ID: 30887252
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human arginase toxicity in mice is reduced by citrulline supplementation.
Mauldin JP; Zeinali I; Kleypas K; Woo JH; Blackwood RS; Jo CH; Stone EM; Georgiou G; Frankel AE
Transl Oncol; 2012 Feb; 5(1):26-31. PubMed ID: 22348173
[TBL] [Abstract][Full Text] [Related]
11. Arginine-metabolizing enzymes in the developing rat small intestine.
De Jonge WJ; Dingemanse MA; de Boer PA; Lamers WH; Moorman AF
Pediatr Res; 1998 Apr; 43(4 Pt 1):442-51. PubMed ID: 9544996
[TBL] [Abstract][Full Text] [Related]
12. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA
Cancer Res; 2002 Oct; 62(19):5443-50. PubMed ID: 12359751
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell sensitivity to arginine deprivation in vitro is not determined by endogenous levels of arginine metabolic enzymes.
Bobak YP; Vynnytska BO; Kurlishchuk YV; Sibirny AA; Stasyk OV
Cell Biol Int; 2010 Nov; 34(11):1085-9. PubMed ID: 20653567
[TBL] [Abstract][Full Text] [Related]
14. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes.
Alexandrou C; Al-Aqbi SS; Higgins JA; Boyle W; Karmokar A; Andreadi C; Luo JL; Moore DA; Viskaduraki M; Blades M; Murray GI; Howells LM; Thomas A; Brown K; Cheng PN; Rufini A
Sci Rep; 2018 Aug; 8(1):12096. PubMed ID: 30108309
[TBL] [Abstract][Full Text] [Related]
16. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA.
El-Mais N; Fakhoury I; Abdellatef S; Abi-Habib R; El-Sibai M
J Ovarian Res; 2021 Jan; 14(1):13. PubMed ID: 33423701
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase.
Yoon CY; Shim YJ; Kim EH; Lee JH; Won NH; Kim JH; Park IS; Yoon DK; Min BH
Int J Cancer; 2007 Feb; 120(4):897-905. PubMed ID: 17096330
[TBL] [Abstract][Full Text] [Related]
18. Citrulline-argininosuccinate-arginine cycle coupled to Ca2+-signaling in rat pancreatic beta-cells.
Nakata M; Yada T; Nakagawa S; Kobayashi K; Maruyama I
Biochem Biophys Res Commun; 1997 Jun; 235(3):619-24. PubMed ID: 9207208
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic renal failure on arginase and argininosuccinate synthetase expression.
Moradi H; Kwok V; Vaziri ND
Am J Nephrol; 2006; 26(3):310-8. PubMed ID: 16809898
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.
Nagasaka H; Tsukahara H; Yorifuji T; Miida T; Murayama K; Tsuruoka T; Takatani T; Kanazawa M; Kobayashi K; Okano Y; Takayanagi M
Metabolism; 2009 Mar; 58(3):278-82. PubMed ID: 19217439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
